| Literature DB >> 34014496 |
Shadi Hamouri1, Sohail Bakkar2, Almoutuz Aljaafreh1, Mohammed Bani Hani1, Hussein Heis1, Ghazi Qasaimeh1, Nasr Alrabadi3, Wisam Al Gargaz4, Haitham Odat4, Yazan Alkurdi1, Tarek Manasreh1, Mohammad Matalka1, Moamin Badwan1.
Abstract
The purpose is to delineate the clinico-pathologic features of papillary thyroid carcinoma (PTC) occurring in a background of Hashimoto's thyroiditis (HT). A retrospective analysis of consecutive PTC patients who underwent surgery at an academic center between Jan. 2010 and Jan. 2020 was performed. The primary end point was to assess whether a background of HT implied a higher likelihood for postoperatively determined high-risk histopathologic features. Accordingly, its implication on initial surgical planning. Tumor high-risk features included aggressive histologic variants, lymphovascular invasion, extrathyroidal extension, multifocality, and positive nodal metastasis. To achieve the primary outcome of interest, a two group-designation was followed: group A (none-HT-group) and group B (HT-group). The two groups were also compared regarding postoperative complications as a secondary outcome of interest. In the specified period, 331 patients were found to have a histologically proven diagnosis of PTC. Group A accounted for 80% (265/331) of the study cohort, while group B accounted for the remainder 20%. PTC was significantly more prevalent in the absence of HT (p < 0.0001). Both groups were comparable in mean-patient-age. However, Group B demonstrated a considerably higher male:female ratio (1:10 vs. 1:3; p = 0.01). All postoperatively determined high-risk histopathologic features were comparable in both groups (p > 0.05). Nevertheless, transient hypoparathyroidism was considerably higher in group B (12% vs. 23%; p = 0.02). A background of HT does not seem to reflect a more aggressive cancerous biologic behavior. Therefore, it should not preclude the conservative surgical strategy adopted by the most recent clinical practice guidelines.Entities:
Keywords: Extent of thyroid surgery; Hashimoto’s thyroiditis; Papillary thyroid carcinoma
Year: 2021 PMID: 34014496 DOI: 10.1007/s13304-021-01087-3
Source DB: PubMed Journal: Updates Surg ISSN: 2038-131X